Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products

Facing the emergence of difficult-to-treat bacterial infections, the perspective of using bacteriophages has re-gained interest in many countries. In terms of pharmaceutical classification in EU and United States, phages are considered as anti-infectious medicinal products and biological products, g...

Descripción completa

Detalles Bibliográficos
Autores principales: Bretaudeau, Laurent, Tremblais, Karine, Aubrit, Françoise, Meichenin, Marc, Arnaud, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287015/
https://www.ncbi.nlm.nih.gov/pubmed/32582101
http://dx.doi.org/10.3389/fmicb.2020.01161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287015/
https://www.ncbi.nlm.nih.gov/pubmed/32582101
http://dx.doi.org/10.3389/fmicb.2020.01161

Ejemplares similares